Medication Treatments

News

MDMA-Assisted Psychotherapy Shows Promise in Treatment for Alcohol Addiction

02/22/2021

Results of the study were published in the Journal of Psychopharmacology.

Results of the study were...

02/22/2021

Addiction Professional

Patients Taking Opioids for Chronic Pain More Likely to Live in Disadvantaged Areas

02/12/2021

A study that was presented this month at the Association of Academic Psychiatrists Annual Meeting suggests that patients being treated for pain with chronic opioid therapy are more likely to live in socially disadvantaged areas and...

A study that was presented this...

02/12/2021

Addiction Professional

In-Office Provision of Buprenorphine Ups Retention Rates for OUD Patients in Study

02/11/2021

A study conducted by Cordant Health Solutions and Northwest Integrated Health in Tacoma, Washington, found that opioid use disorder patients who had been prescribed buprenorphine demonstrated higher rates of retention and improved health...

A study conducted by Cordant...

02/11/2021

Addiction Professional

News

Pa. Bill to Add Buprenorphine Prescribing Restrictions Revived

02/03/2021

A Pennsylvania state senator has announced plans to resuscitate a bill that would create new regulations around the provision of buprenorphine in the state.

A Pennsylvania state senator has...

02/03/2021

Addiction Professional

News

Biden Administration to Halt Plans to Nix X-Waiver Requirement

01/26/2021

A decision made by HHS in the waning days of the Trump presidency to publish new guidelines that include an exemption from certain requirements under the Controlled Substances Act for physicians who are licensed under state law and possess...

A decision made by HHS in the...

01/26/2021

Addiction Professional

News

HHS Eliminates X-Waiver Requirement for DEA-Licensed Physicians

01/15/2021

HHS on Thursday announced that it will publish new guidelines that will expand access to medication-assisted treatment for opioid use disorder by exempting physicians from certain certification requirements necessary for prescribing...

HHS on Thursday announced that...

01/15/2021

Addiction Professional

News

Medication-Assisted Treatment for Methamphetamine Use Disorder? NIH Study Shows Potential

01/14/2021

Findings in a Phase III clinical trial released by NIH showed that a combination of two medications—injectable naltrexone and oral bupropion—were safe and effective in the treatment of adults with moderate or severe methamphetamine use...

Findings in a Phase III clinical...

01/14/2021

Addiction Professional

News

Physician-Pharmacist Buprenorphine Treatment Collaboration Shows Strong Returns

01/12/2021

Results of a NIDA-supported pilot study released on Monday showed that collaboration between physicians and pharmacists could lead to improved medication adherence among patients being treated for opioid use disorder.

Results of a NIDA-supported...

01/12/2021

Addiction Professional

News

Spectrum to Provide MAT Services for Incarcerated Individuals in Massachusetts

12/02/2020

Spectrum Health Systems, a Worcester, Massachusetts-based not-for-profit addiction treatment provider, announced that it has been awarded a four-year, $43.5 million contract by the Massachusetts Department of Correction to provide...

Spectrum Health Systems, a...

12/02/2020

Addiction Professional

News

Stimulant Summit: Providers Must Weather Storm as COVID Complicates Stimulant Surge

11/21/2020

With the lethality, availability and use of stimulants all greatly increasing in the U.S. in recent years and the COVID-19 pandemic complicating the treatment landscape for patients and practitioners alike, it’s critical for providers to...

With the lethality, availability...

11/21/2020

Addiction Professional

Browse Our Other Brands

Medication Treatments

Browse Our Other Brands

Specialties

Events

Year Round Education

HMP Global Products